Damora Therapeutics, Inc. (DMRA) — Institutional Holders, Q2 2026 (page 2)
101 institutional investment managers reported a DMRA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.7B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 101. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DMRA 13F holders ranked 101–101 of 101
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#101 · 40,544 sh | 40,544 | — | — | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.